Q: Hi, Could you please comment on PHA earnings. Thank you
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi Peter,
Now that GUD has been delisted from S&P/TSX, can I still buy or sell GUD shares? If so, what exchange?
Terry
Now that GUD has been delisted from S&P/TSX, can I still buy or sell GUD shares? If so, what exchange?
Terry
Q: HI!
I am wondering about the potential short and long term growth of VTRS as the sister company of PFE producing their generics?
Thanks Ben.
I am wondering about the potential short and long term growth of VTRS as the sister company of PFE producing their generics?
Thanks Ben.
-
INVESCO QQQ Trust (QQQ)
-
iShares U.S. Medical Devices ETF (IHI)
-
SPDR S&P Health Care Equipment ETF (XHE)
-
Vanguard Information Technology ETF (VGT)
Q: Can you suggest some eft's for the above sectors? Do have a couple tech companies in my portfolio such as Lightspeed and Shopify, but no "big" ones like Google, Apple etc. and WELL and PRN. Would like to find ETF's which may help to broaden my exposure in these sectors.
Q: Would you hold both of these companies, or are they too similar?
Thanks!
Thanks!
Q: Good morning 5i, question for you on prospects for Portage Biotech for growth, a friend of mine who was an earlier investor in this company, really likes the space and specifically the Chairman and Director Greg Bailey as he said he has a great track record with previous companies.
This is from Portage's site (CEO of Juvanescence. Managing Partner of Palantir Group, Inc, co-founder of Ascent Healthcare Solutions, VirnetX Inc. (Biohaven (BHVN:NYSE), and DuraMedic Inc. He was the initial financier and an independent Director of Medivation, Inc. (MDVN:NASDAQ), from 2005 to 2012. He also served as the Managing Director and co-Head of Life Sciences at MDB Capital Group LLC from May 2004 to December 2006.)
Do you know of Greg and would you feel comfortable with his history? I am guessing you do not know much about the company and in the biotech/cancer space there is tons of risk so that is fully understood, but looking to add to that sector for long term growth 15 plus years out.
This is from Portage's site (CEO of Juvanescence. Managing Partner of Palantir Group, Inc, co-founder of Ascent Healthcare Solutions, VirnetX Inc. (Biohaven (BHVN:NYSE), and DuraMedic Inc. He was the initial financier and an independent Director of Medivation, Inc. (MDVN:NASDAQ), from 2005 to 2012. He also served as the Managing Director and co-Head of Life Sciences at MDB Capital Group LLC from May 2004 to December 2006.)
Do you know of Greg and would you feel comfortable with his history? I am guessing you do not know much about the company and in the biotech/cancer space there is tons of risk so that is fully understood, but looking to add to that sector for long term growth 15 plus years out.
Q: Can I have your opinion on the takeover of BioTelemetry by Royal Philips at $72/share.
Thank you and Happy Holidays.
Thank you and Happy Holidays.
Q: What are your current thoughts on AND ? Thank you.
-
Illumina Inc. (ILMN)
-
Hologic Inc. (HOLX)
-
Teladoc Health Inc. (TDOC)
-
WELL Health Technologies Corp. (WELL)
-
Guardant Health Inc. (GH)
-
QuidelOrtho Corp Com (QDEL)
-
Repligen Corporation (RGEN)
Q: Could you rank the US Healthcare stocks + WELL in terms of management, balance sheet, and long-term growth prospective? Thanks.
Q: Between NVTA, CRSP, EXAS which one will prefer to start a new position - from a quality of product and pipeline - runway and performance perspective. Thanks
Q: What do you think of well's update today.
Q: What covid 19 vaccine stocks would you recommend --- if ay Pfizer, Moderna, Johnson and Johnson, Astro Zeneca or others.
Q: On a steady decline since $8.41 on Oct 16,though seems to have found support around $6.70-6.86 near the $6.75 Bought Deal price. This morning Well announced that it will be profitable in the Q.Is it unusual to preannounce? When will it reports the Q?.Is it timely to set up a position here especially in light of approval & subsequent distribution of Vaccine? Txs for u usual great services & views
Q: Good morning... Wondering your thoughts on TRIL's clinical trial results, if there are any catalysts in the pipeline and if it's worth a buy at current levels.
thx, Mark
thx, Mark
-
Veeva Systems Inc. Class A (VEEV)
-
CRISPR Therapeutics AG (CRSP)
-
Seagen Inc. (SGEN)
-
Unity Software Inc. (U)
Q: Hi,
I am interested in your thoughts on these companies. EXAS and CRSP are a part of the recently fast moving ARKG ETF but both seem to offer products that would appear to offer continued growth. Would that be correct? The other two, VEEV and SGEN have been struggling price wise lately, SGEN is starting to see improvement, do you think VEEV still has good potential into the next year or two? I've also noticed more comments on Unity Software, but do not know much about it and it isn't listed in your data base. Take as many points as you need, as I'm asking multiple questions. Thanks for all your insight and suggestions, all very much appreciated!
Dawn
I am interested in your thoughts on these companies. EXAS and CRSP are a part of the recently fast moving ARKG ETF but both seem to offer products that would appear to offer continued growth. Would that be correct? The other two, VEEV and SGEN have been struggling price wise lately, SGEN is starting to see improvement, do you think VEEV still has good potential into the next year or two? I've also noticed more comments on Unity Software, but do not know much about it and it isn't listed in your data base. Take as many points as you need, as I'm asking multiple questions. Thanks for all your insight and suggestions, all very much appreciated!
Dawn
Q: Hi,
Now that the IPO has come out and the feeding frenzy pushed the stock to approx $71 on day one, it has retraced quite a bit from that one day high but still double the IPO price today (Dec 15). I will wait for this one to settle a bit more in the next several weeks but just curious what you think a fair entry price range would be given they are already profitable vs several other recent IPO's in the same space or other space for that matter? Or should one wait for the outcome of phase 2 and 3 trials before dipping their toes in on this one? I would only initiate a 1/3 position.
I realize the euphoria right now is around covid but longer term they seem to have a unique product/platform that could be applicable elsewhere, ie AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health.
Cheers....
Now that the IPO has come out and the feeding frenzy pushed the stock to approx $71 on day one, it has retraced quite a bit from that one day high but still double the IPO price today (Dec 15). I will wait for this one to settle a bit more in the next several weeks but just curious what you think a fair entry price range would be given they are already profitable vs several other recent IPO's in the same space or other space for that matter? Or should one wait for the outcome of phase 2 and 3 trials before dipping their toes in on this one? I would only initiate a 1/3 position.
I realize the euphoria right now is around covid but longer term they seem to have a unique product/platform that could be applicable elsewhere, ie AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health.
Cheers....
Q: I am trying to understand Pfizer. In September it was trading at $36 and change. Today after all the good news about the vaccine it is at $39 and change. This seems like a small increase given the good it is doing and news, etc. However, if there were reports of a few bad reactions (or worse, sorry to say), the stock would tank. Can you help me understand this or maybe I am seeing it all wrong. Thanks again.
Q: Receuved a notice of ipo for MCI OneHealth Technologies Inc. Do you have any information you can share on this one?
Q: I have owned CRH medical for quite sometime and it has not done to much for me. Do you think a switch into GUD would be better?
Q: Hi and good day. Could you please provide some worst case scenarios with GUD stock and share price. Thanks eh